Maybe. While NanoKnife effectively targets and destroys cancerous tissue, there is a possibility of recurrence. Studies have shown that in-field recurrence rates (within the treated area) range from approximately 2.7% to 9.8%, while out-of-field recurrence rates (outside the treated area) can be around 12.5%. Regular follow-up with PSA tests and imaging is crucial to monitor for any signs of recurrence and to manage them promptly. PMCPMC